The CAS (Crk-associated substrate) adaptor protein family consists of four
members: CASS1/BCAR1/p130Cas, CASS2/NEDD9/HEF1/Cas-L, CASS3/EFS/Sin and CASS4/HEPL. While
CAS proteins lack enzymatic activity, they contain specific recognition and binding sites
for assembly of larger signaling complexes that are essential for cell proliferation,
survival, migration, and other processes. All family members are intermediates in
integrin-dependent signaling pathways mediated at focal adhesions, and associate with FAK
and SRC family kinases to activate downstream effectors regulating the actin cytoskeleton.
Most studies of CAS proteins to date have been focused on the first two members, BCAR1 and
NEDD9, with altered expression of these proteins now appreciated as influencing disease
development and prognosis for cancer and other serious pathological conditions. For these
family members, additional mechanisms of action have been defined in receptor tyrosine
kinase (RTK) signaling, estrogen receptor signaling or cell cycle progression, involving
discrete partner proteins such as SHC, NSP proteins, or AURKA. By contrast, EFS and CASS4
have been less studied, although structure-function analyses indicate they conserve many
elements with the better-known family members. Intriguingly, a number of recent studies
have implicated these proteins in immune system function, and the pathogenesis of
developmental disorders, autoimmune disorders including Crohn’s Disease,
Alzheimer’s Disease, cancer, and other diseases. In this review, we summarize the
current understanding of EFS and CASS4 protein function in the context of the larger CAS
family group.